Ophthalmology

Clinical evidence, research, and medical intelligence in Ophthalmology.

Uremic Ocular Surface Disease Review Links CKD to Tear Biomarkers

A narrative review examines uremic ocular surface disease in chronic kidney disease, with focus on pathophysiology, tear biomarkers, and calcineurin inhibitors.

By Dr. A. Nikhil Krishnan, MBBS · Oct 26, 2026 · 6 min read

Ophthalmology·Front Immunol

mNGS Guides Vancomycin Therapy in oGVHD Endophthalmitis Case

Aqueous humor mNGS identified Staphylococcus epidermidis in chronic ocular GVHD endophthalmitis and guided targeted vancomycin without vitrectomy.

Oct 25, 2026

Ophthalmology·BMJ Open

Kaupapa Māori Scoping Review Targets Inequities in Māori Eye Health

A BMJ Open protocol outlines a scoping review of Māori eye health interventions and how often Kaupapa Māori…

Oct 25, 2026

Ophthalmology·BMJ Open

Dry Eye Disease Affects 40.4% of Adults With Diabetes in Ethiopia

A multicentre Ethiopian study found symptomatic dry eye disease in 40.4% of adults with diabetes, with higher odds…

Oct 25, 2026

Ophthalmology·PLOS ONE

Eye Movement Perimetry Shows Promise for Glaucoma Triage in Tanzania

A Tanzania study found eye movement perimetry matched severe visual field loss with high sensitivity, but false positives…

Oct 24, 2026

Ophthalmology·Nat Rev Onc

RPE65 Retinitis Pigmentosa Shows Wide Clinical Variability

Nine Japanese patients with RPE65-related retinitis pigmentosa showed early childhood onset, severe vision loss in many cases, and…

Oct 24, 2026

Ophthalmology·Nature

Retinal AI Model Predicts Four Conditions From One Fundus Image

A multi-task retinal fundus AI model classified diabetic retinopathy, glaucoma, AMD and cardiovascular risk in one pass, with…

Oct 24, 2026

Ophthalmology·Nature

F2D-RetinaNet uses fractional operators to improve retinal disease grading

A new dual-path retinal AI combines vessel segmentation and lesion enhancement, reaching strong test performance across diverse fundus…

Oct 23, 2026

Ophthalmology·Nature

Autonomous AI narrows diabetic retinopathy screening gaps in youth

A prospective study found autonomous AI diabetic eye exams achieved equivalent screening completion in White and non-White youth…

Oct 23, 2026

Ophthalmology·ACC-PRO

Atsena eye gene therapy readout keeps 2028 filing in view

Atsena is pressing ahead with eye disease gene therapy development after a readout that could still support a…

Oct 23, 2026

Ophthalmology

Clinical evidence, research, and medical intelligence in Ophthalmology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.